Treating coronary disease and the impact of endothelial dysfunction.
Treating coronary disease and the impact of endothelial dysfunction.
复制标题
DOI:
10.1016/j.pcad.2014.10.004
复制
发表时间:
2015-03
影响因子:
9.1
通讯作者:
Lerman, Amir
中科院分区:
文献类型:
--
作者:
Matsuzawa, Yasushi;Guddeti, Raviteja R.;Kwon, Taek-Geun;Lerman, Lilach O.;Lerman, Amir
Ischemic heart disease is the leading cause of morbidity and mortality throughout the world. Many clinical trials have suggested that lifestyle and pharmacologic interventions are effective in attenuating atherosclerotic disease progression and events development. However, an individualized approach with careful consideration to comprehensive vascular health is necessary to perform successful intervention strategies. Endothelial dysfunction plays a pivotal role in the early stage of atherosclerosis and is also associated with plaque progression and occurrence of atherosclerotic complications. The assessment of endothelial function provides us with important information about individual patient risk, progress and vulnerability of disease, and guidance of therapy. Thus, the application of endothelial function assessment might enable clinicians to innovate ideal individualized medicine. In this review, we summarize the current knowledge on the impact of pharmacological therapies for atherosclerotic cardiovascular disease on endothelial dysfunction, and argue for the utility of non-invasive assessment of endothelial function aiming at individualized medicine.
登录
查看更多内容
影响因子:
3.2
作者:
Bank, Alan J.;Kelly, Aaron S.;Gonzalez-Campoy, J. Michael
通讯作者:
Gonzalez-Campoy, J. Michael
影响因子:
168.9
作者:
Dormandy, JA;Charbonnel, B;Taton, J
通讯作者:
Taton, J
影响因子:
158.5
作者:
Duckworth, William;Abraira, Carlos;Huang, Grant D.
通讯作者:
Huang, Grant D.
DOI:
10.1097/mco.0b013e3283439622
发表时间:
2011-03-01
影响因子:
3.1
作者:
Egert, Sarah;Stehle, Peter
通讯作者:
Stehle, Peter
影响因子:
37.8
作者:
Broeders, MAW;Doevendans, PA;van der Zee, R
通讯作者:
van der Zee, R